AT7519 HCl
| CAS No. | 902135-91-5 | Cat. No. | BCP01950 |
| Name | AT7519 HCl | ||
| Synonyms | AT 7519 HCl;AT-7519 HCl;AT7519 Hydrochloride ;AT-7519 Hydrochloride;AT 7519 Hydrochloride; | ||
| Formula | C16H17Cl2N5O2.HCl | M. Wt | 418.71 |
| Description | AT7519 HCl is a potent inhibitor of CDKs, with IC50s of 210, 47, 100, 13, 170, and <10 nM for CDK1, CDK2, CDK4 to CDK6, and CDK9, respectively.AT-7519 is an orally bioavailable small molecule CDK inhibitor with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation. CDKs are serine/theronine kinases involved in regulation of the cell cycle and may be overexpressed in some types of cancer cells. | ||
| Pathways | Cell Cycle/DNA Damage | ||
| Targets | CDK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.